Affective well-being is positively linked to regular exercise. Therefore, it is important to identify the factors that influence intra-individual variability of affective well-being. This study investigated (1) whether affective responses vary within an individual and (2) how affective responses are associated with a motive-incentive fit and a skill-task fit. A total of 107 adults (66% females, = 41.79 years old, 58% doing no exercise) took part in three exercise sessions in a random order. Each session lasted 30 min with a break of 10 min between. The sessions were similarly structured but covered diverse activity incentives (e.g., figure vs. social contact vs. aesthetic movements). Intraclass correlation coefficients showed a very high within-person variation of affective valence and enjoyment across the exercise sessions. The results of multi-level regression analyses revealed that associations between perceived competence, considered to be an indicator of the skill-task fit, and affective well-being were moderate to high, whereas those between motive-incentive fit and affective well-being were low to moderate.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826600 | PMC |
http://dx.doi.org/10.3390/ijerph18020549 | DOI Listing |
Eat Weight Disord
January 2025
Faculty of Science and Technology, Department of Psychology, Bournemouth University, Poole, UK.
Purpose: This study aimed to explore emotional functioning in individuals with varying levels of orthorexia nervosa (ON) symptoms. Given the established links between emotion dysregulation and other eating disorders (EDs), and the conceptualization of ON within the ED spectrum, this research sought to examine the relationships between ON symptomatology and emotion regulation strategies, alexithymia, and beliefs about emotions.
Methods: A large sample (N = 562) completed self-report measures with high psychometric properties, assessing ON traits (E-DOS), emotion regulation strategies (DERS-SF and ERQ), alexithymia (TAS-20), and beliefs about emotions (ERQ).
Neuropsychopharmacology
January 2025
Department of Psychiatry, Oxford University, Warneford Hospital, Oxford, UK.
There is an ongoing need to identify novel pharmacological agents for the effective treatment of depression. One emerging candidate, which has demonstrated rapid-acting antidepressant effects in treatment-resistant groups, is nitrous oxide (NO)-a gas commonly used for sedation and pain management in clinical settings and with a range of pharmacological effects, including antagonism of NMDA glutamate receptors. A growing body of evidence suggests that subanaesthetic doses of NO (50%) can interfere with the reconsolidation of maladaptive memories in healthy participants and across a range of disorders.
View Article and Find Full Text PDFJ Dairy Sci
January 2025
Département des Sciences Cliniques, Faculté de Médecine Vétérinaire, Université de Montréal, 3200 rue Sicotte, St-Hyacinthe, QC, J2S 2M2, Canada. Electronic address:
Dairy calf welfare assessment tools focusing on the pre-weaning period have been proposed in recent research. Despite the existence of these tools, assessing the welfare and health-related quality of life (HRQoL) of dairy calves remains challenging. These difficulties may stem from the complexity of assessing all dimensions of calf welfare and the validity, reliability, and feasibility of the indicators used in assessment tools.
View Article and Find Full Text PDFPsychiatry Res Neuroimaging
January 2025
Departamento de Morfologia e Genética, Escola Paulista de Medicina, Universidade Federal de São Paulo - UNIFESP, São Paulo, SP, Brazil. Electronic address:
Alcohol use disorder (AUD) is a multifactorial disease closely related to neurodevelopment and environmental factors that influence behavior. This study explored the relationships between brain volume and behavior from an Exploratory Structural Equation Modeling (ESEM) based on the Research Domain Criteria. High-resolution magnetic resonance imaging scans were acquired from recent patients with AUD (n = 50) and healthy controls (HC=50).
View Article and Find Full Text PDFPsychooncology
January 2025
Integrative Biological and Behavioral Sciences, Division of Extramural Scientific Programs, National Institute on Minority Health and Health Disparities, Rockville, Maryland, USA.
Background: Nearly 20% of US cancer survivors develop cardiovascular disease (CVD) from cardiotoxic cancer treatments. Patients and providers may consider alternative treatments to lower cardiotoxicity risk, but these may be less effective at preventing relapse/recurrence, presenting a difficult tradeoff.
Aims: This study explored survivors' cancer treatment decision-making when weighing this tradeoff.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!